InvestorsHub Logo
Followers 37
Posts 7163
Boards Moderated 1
Alias Born 09/06/2014

Re: Gailm post# 91874

Thursday, 01/05/2017 8:42:21 AM

Thursday, January 05, 2017 8:42:21 AM

Post# of 331634
If/when the FDA clears the ActiPatch for OTC, there's going to be INCREDIBLE selling pressure here. This stock could close in the RED that day.

Assuming the company is still operating, of course.

The most obvious solution for the Whelans: scuttle the company by filing for bankruptcy protection, declare the loans in default, and transfer the patents to IBEX. Then IBEX can possibly sell the patents for a few million and laugh all the way to the bank.

That is the OBVIOUS solution. Judging from the History of Bioelectronics and the Education its shareholders have received about this company's propensity for lying and breaking SEC and FDA laws, I think it is also the most LIKELY outcome.

BIEL might get more $$$ for the patents if they wait for FDA clearance before cashing out on the patents. So it's a waiting game, IMO. Kind of interesting to watch, but also kind of sad.

BIEL might get very little $$$ for the patents, with or without FDA clearance. Prospective buyers who looks at the books and sees the failure of the ActiPatch in the UK might assume that the ActiPatch is going to also be a commercial failure in the US.